Conversely, we have also demonstrated that COX-2 expression is higher in breast tumors with elevated expression of CYP24A1, an enzyme responsible for VD3 catabolizing, whereas tumors with high CYP27B1 expression (enzyme responsible for VD3 synthesis) exhibit lower COX-2 expression. The gene discussed is CYP27B1; the disease is breast neoplasm.